(Q62271332)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22751508%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

title

Cardiovascular disease: Should statin therapy be expanded in patients with CKD? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22751508%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference

Kristen L. Jablonski

1

0 references

author name string

Michel Chonchol

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22751508%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Kristen L Jablonski

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22751508%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

language of work or name

English

0 references

publication date

3 July 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22751508%20AND%20SRC:MED&resulttype=core&format=json

Nature Reviews Nephrology

6 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22751508%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22751508%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22751508%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

page(s)

440-441

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22751508%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/nrneph.2012.142

6 February 2020

exact match

0 references

cites work

The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.142

Statins for the primary prevention of cardiovascular disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.142

Statins and all-cause mortality in high-risk primary prevention: a meta-analysis of 11 randomized controlled trials involving 65,229 participants

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.142

Efficacy of statins for primary prevention in people at low cardiovascular risk: a meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.142

The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.142

Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.142

Rosuvastatin and cardiovascular events in patients undergoing hemodialysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.142

Role of statins in preventing adverse cardiovascular outcomes in patients with chronic kidney disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.142

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.142

Protocol for a prospective collaborative overview of all current and planned randomized trials of cholesterol treatment regimens. Cholesterol Treatment Trialists' (CTT) Collaboration

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22751508